Cargando…

Short-Term Effects of Gender-Affirming Hormone Therapy on Dysphoria and Quality of Life in Transgender Individuals: A Prospective Controlled Study

BACKGROUND: Gender affirming hormone therapy (GAHT), whilst considered the standard of care in clinical guidelines for the treatment of many transgender (trans) people is supported by low quality evidence. In this prospective longitudinal controlled study, we aimed to examine the effect of newly com...

Descripción completa

Detalles Bibliográficos
Autores principales:	Foster Skewis, Lucas, Bretherton, Ingrid, Leemaqz, Shalem Y., Zajac, Jeffrey D., Cheung, Ada S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8358932/ https://www.ncbi.nlm.nih.gov/pubmed/34394009 http://dx.doi.org/10.3389/fendo.2021.717766

Ejemplares similares

Effects of gender-affirming hormone therapy on insulin resistance and body composition in transgender individuals: A systematic review
por: Spanos, Cassandra, et al.
Publicado: (2020)

Insulin resistance in transgender individuals correlates with android fat mass
por: Bretherton, Ingrid, et al.
Publicado: (2021)

SAT413 Feminising Gender Affirming Hormone Therapy Prolongs QTc Interval
por: Angus, Lachlan, et al.
Publicado: (2023)

LBODP089 Effects Of Low-dose Oral Micronised Progesterone On Sleep, Psychological Distress And Breast Development In Transgender Individuals Undergoing Feminising Hormone Therapy: A Prospective Controlled Study
por: Nolan, Brendan J, et al.
Publicado: (2022)

Effect on Kidney Function During Gender Affirming Hormonal Treatment in Transgender Individuals
por: Maheshwari, Arvind Kumar, et al.
Publicado: (2021)

Cardiovascular Risk Associated With Gender Affirming Hormone Therapy in Transgender Population
por: Aranda, Gloria, et al.
Publicado: (2021)

Sociodemographic and Clinical Characteristics of Transgender Adults in Australia
por: Cheung, Ada S., et al.
Publicado: (2018)

MON-196 Gender-Affirming Hormonal Therapy and Incidence of Metabolic Syndrome and Cardiovascular Events in Patients with Gender Dysphoria
por: Mok, Mary, et al.
Publicado: (2019)

Age at First Experience of Gender Dysphoria Among Transgender Adults Seeking Gender-Affirming Surgery
por: Zaliznyak, Michael, et al.
Publicado: (2020)

Physical and Sociodemographic Features Associated With Quality of Life in Transgender Individuals Using Gender-Affirming Hormone Therapy
por: Da Silva, Eliane Dias, et al.
Publicado: (2021)

Gender-affirming hormone therapy induces specific DNA methylation changes in blood
por: Shepherd, Rebecca, et al.
Publicado: (2022)

Factors associated with suicide attempts among Australian transgender adults
por: Zwickl, Sav, et al.
Publicado: (2021)

Bone Microarchitecture in Transgender Adults: A Cross‐Sectional Study
por: Bretherton, Ingrid, et al.
Publicado: (2022)

OR31-04 Testosterone Therapy On Gender Dysphoria, Depression, And Suicidality In Transgender And Gender Diverse Individuals Seeking Masculinisation: A Randomised Controlled Trial
por: Nolan, Brendan J, et al.
Publicado: (2023)

Prolactinoma in a Male to Female Transgender Woman on Gender Affirming Hormone Therapy
por: Harned, Leighton K, et al.
Publicado: (2021)

Correction to: Factors associated with suicide attempts among Australian transgender adults
por: Zwickl, Sav, et al.
Publicado: (2021)

PMON280 Effect of Gender Affirming Hormone Therapy (GAHT) on Adipose Tissue Morphology and Metabolism in Transgender Individuals
por: Shah, Manasi S, et al.
Publicado: (2022)

Effects of low-dose oral micronised progesterone on sleep, psychological distress, and breast development in transgender individuals undergoing feminising hormone therapy: a prospective controlled study
por: Nolan, Brendan J, et al.
Publicado: (2022)

Cyproterone acetate or spironolactone in lowering testosterone concentrations for transgender individuals receiving oestradiol therapy
por: Angus, Lachlan, et al.
Publicado: (2019)

Feminizing Hormone Therapy Prescription Patterns and Cardiovascular Risk Factors in Aging Transgender Individuals in Australia
por: Balcerek, Matthew I., et al.
Publicado: (2021)

ODP414 Incidence of Suicidal Events in Transgender Patients with Initiation of Gender Affirming Hormone Therapy
por: Elliott, Karma-Jaya, et al.
Publicado: (2022)

Selective Estrogen Receptor Modulators: A Potential Option For Non-Binary Gender-Affirming Hormonal Care?
por: Xu, Jane Y., et al.
Publicado: (2021)

Forensic alcohol calculations in transgender individuals undergoing gender‐affirming hormonal treatment
por: Maskell, Peter D., et al.
Publicado: (2022)

Abstract 65: Effects of gender affirming hormone therapy on metabolic health and body composition in gender dysphoria
por: Kiran, Baratam Hari, et al.
Publicado: (2022)

SUN-046 Prevalence of Polycythaemia with Different Formulations of Testosterone Therapy in Transmasculine Individuals
por: Nolan, Brendan J, et al.
Publicado: (2020)

Clinical pearls of gender-affirming hormone therapy in transgender patients
por: Irving, Amanda, et al.
Publicado: (2018)

Gender-affirming Hormone Therapy and Risk of Diabetes in Transgender Persons
por: Tangpricha, Vin
Publicado: (2022)

Cardiovascular Risk in Transgender People With Gender-Affirming Hormone Treatment
por: Masumori, Naoya, et al.
Publicado: (2023)

MON-195 Trans-transgender Female: Gender Identity Reversal Following Irreversible Gender Affirming Surgeries
por: Korpaisarn, Sira, et al.
Publicado: (2019)

Cardiovascular Risk Factors in Transgender Women Undergoing Long-Term Gender-Affirming Hormone Therapy: A Cross-Sectional Study
por: Alvares, Leonardo A M, et al.
Publicado: (2021)

Gender Affirming Body Contouring and Physical Transformation in Transgender Individuals
por: Asokan, Arjun, et al.
Publicado: (2022)

Sexual Satisfaction After Gender Affirmation Surgery in Transgender Individuals
por: Jerome, Renard R, et al.
Publicado: (2022)

Characterising body composition and bone health in transgender individuals receiving gender‐affirming hormone therapy
por: Ford, Ky, et al.
Publicado: (2022)

The return of spermatogenesis in transgender women ceasing gender-affirming hormone therapy
por: Yau, Mabel, et al.
Publicado: (2023)

Magnetic Resonance Spectroscopy in Gender Dysphoria
por: Collet, Sarah Marie, et al.
Publicado: (2021)

SAT422 Gender Affirming Hormone Therapy in a Non-Binary Individual with Swyer Syndrome
por: Yohannan, Jiby M, et al.
Publicado: (2023)

Antidepressant prescribing in transgender and nonbinary individuals diagnosed with gender dysphoria and mood or anxiety disorders
por: Tiefenthaler, Casey M, et al.
Publicado: (2023)

A Cross Sectional Analysis of the Prevalence of Co-Morbidities in Older Transgender Individuals Receiving Hormone Affirming Therapy in Comparison With the General Population
por: Breda, Ido, et al.
Publicado: (2021)

Gender Dysphoria – Prevalence and Co-Morbidities in an Irish Adult Population
por: Judge, Ciaran, et al.
Publicado: (2014)

Gender-Affirming Hormone Therapy, Vascular Health and Cardiovascular Disease in Transgender Adults
por: Connelly, Paul J., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_9vod8toktf1il78kv57nlql81p